Cartwright D W
Royal Brisbane and Women's Hospital, RBH Post Office, Brisbane, Queensland 4029, Australia.
Arch Dis Child Fetal Neonatal Ed. 2004 Nov;89(6):F504-8. doi: 10.1136/adc.2004.049189.
To describe the use of percutaneously inserted silicone central venous lines (CVLs) in neonates at the Royal Brisbane and Women's Hospital, Australia.
Data for all infants admitted from 1 January 1984 until 31 December 2002 who had a CVL were examined in the neonatal database, completed from paper records and patient charts where necessary. Autopsy reports of all babies who died with a catheter in place were reviewed.
There were 18,761 admissions, 2186 catheters in 1862 babies for a total of 35,159 days (median 14 days, range 1-99 days). The tip was in the right atrium for 1282 (58.6%) of the catheters. A total of 142 babies (7.6%) died with a CVL in place, 89 (4.8%) with the catheter tip in the right atrium. Thirty two of these 89 babies had an autopsy. No autopsies reported tension in the pericardium or milky fluid resembling intralipid. One case (0.05% of catheters) of non-lethal pericardial effusion occurred in a baby whose catheter was inappropriately left coiled in the right atrium. There were no cases of pleural effusion related to CVL use. Most (1523, 69.7%) were removed electively. Septicaemia occurred during the life of 116 catheters (5.3%).
This is the largest series of percutaneously inserted silicone central venous catheters reported. It illustrates the safety of these catheters in this context. It highlights the value of keeping prospective records on such catheters. Catheters with their tips in the right atrium and not coiled did not cause pericardial effusion. Strict insertion and management principles for CVLs should be adhered to.
描述澳大利亚皇家布里斯班妇女医院在新生儿中使用经皮插入式硅胶中心静脉导管(CVL)的情况。
在新生儿数据库中检查了1984年1月1日至2002年12月31日期间所有接受CVL的婴儿的数据,必要时从纸质记录和患者病历中补充完整。对所有导管在位时死亡婴儿的尸检报告进行了审查。
共收治18761例婴儿,1862例婴儿置入2186根导管,总计35159天(中位数14天,范围1 - 99天)。1282根(58.6%)导管尖端位于右心房。共有142例(7.6%)婴儿导管在位时死亡,其中89例(4.8%)导管尖端位于右心房。这89例婴儿中有32例进行了尸检。尸检报告中未提及心包张力或类似脂质乳剂的乳白色液体。1例婴儿(占导管的0.05%)发生非致命性心包积液,其导管不当盘绕在右心房。未发生与CVL使用相关的胸腔积液病例。大多数导管(1523根,69.7%)是择期拔除的。116根导管(5.3%)在使用期间发生败血症。
这是报道的经皮插入式硅胶中心静脉导管的最大系列病例。它说明了在此背景下这些导管的安全性。强调了对此类导管进行前瞻性记录的价值。导管尖端位于右心房且未盘绕不会导致心包积液。应严格遵守CVL的插入和管理原则。